Gurdev Dave Singh - 05 Aug 2021 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role: Chief Medical Officer, Director, 10%+ Owner
Signature: /s/ Brad Amman as attorney-in-fact for G.Dave Singh
Issuer symbol: VVOS
Transactions as of: 05 Aug 2021
Net transactions value: +$81,600
Form type: 4
Filing time: 10 Aug 2021, 21:44:38 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	VVOS	Common Stock						3,219,705	05 Aug 2021	See footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VVOS	Stock Option (Right to Buy)	Award	$81,600	+30,000	+180%	$2.72^*	46,667	05 Aug 2021	Common Stock	46,667	$2.72	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by Himmat LP, of which reporting person is a member and manager.
F2	30,000 stock options granted on August 5, 2021. One-half vested immediately and one-eighth vests quarterly every three months through August 5, 2022.